|This message contains images. If you don't see images, click here to view.|
Advertise in this news brief.
We wanted you to be aware that the FDA has granted accelerated approval of IBRANCE® (palbociclib) for the treatment of postmenopausal women with ER+/HER2- advanced breast cancer. Click here to see the press release!
We wanted you to be aware that FDA-approved Hysingla™ ER (hydrocodone bitartrate) extended-release tablets CII has commercially launched in the U.S.
Please click here to view the press release.
Click here for a CME/CEU activity on Improving Treatment of Atrial Fibrillation and Stoke
Otezla® (apremilast) is approved for the treatment of patients with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy. Please click here for more information.
Click here to view our Complimentary Online CME/CEU Webcasts
Study: Genetic markers for PTSD linked to immune system response
Researchers have identified genetic markers associated with post-traumatic stress disorder that are linked with regulating the immune system, Medical News Today reported. This finding may lead to the ability to identify individuals at risk of PTSD.
Study: You may be your germs — microbe genes slipped into human DNA
Evolutionary diagrams usually connect humans and monkeys with common primate ancestors, but now, scientists say there's a missing link that deserves a spot on that family tree
— our bacteria, fungi, and viruses.
Though most of our genes come from primate ancestors, many of them slipped into our DNA from microbes living in our bodies, says British researcher Alastair Crisp.
Rett Syndrome treatment may lie in targeting 'long genes'
Medical News Today
A new study suggests targeting long genes could be a new treatment avenue for the devastating childhood disorder Rett Syndrome. The authors found that lack of the MeCP2 protein that is the hallmark of the disease causes subtle — but widespread — overexpression of long genes with functions important for the brain.
Patient empowerment: The secret sauce behind 23andMe's pipeline-in-a-database strategy
In announcing the formation of a new therapeutics division, consumer genetics company 23andMe is evolving from data broker to data user, suggesting they have not only a strong belief in the underlying “pipeline in a database” concept, but also that they believe that with the right team, they can do a better job of finding new drugs than the established pharma companies with whom they’ve been partnering.
BioFeedback for immunoglobulin is a health outcomes reporting program that provides clinical feedback on the use of immunoglobulin in autoimmune-related disorders. Physicians and medical directors can now deploy clinical interventions when they have the greatest impact on healthcare quality and costs.
Request more information or schedule a personal introduction.
The vast potential of precision medicine
Hospital & Health Networks
A new, "big data" initiative will leverage a million genomes, disease courses, therapeutic options and health histories to better treat one patient: You.
In his 2016 budget, President Barack Obama has included an allocation of $130 million to fund the recruitment of a representative cohort of at least 1 million volunteers nationwide. Their detailed health histories and complete genomic makeup will be documented and pooled electronically.
Precision medicine: The future or simply politics?
The Journal of the American Medical Association
Barrett Rollins, M.D., Ph.D., chief scientific officer at the Dana-Farber Cancer Institute, tells an anecdote to illustrate the promise of “precision medicine.” A 35-year-old patient at Dana-Farber was dying of myeloid sarcoma, a rare tumor consisting of a solid collection of leukemic cells outside of the bone marrow. Although the man was about to enter hospice care, he consented to having his tumor’s genome sequenced.
Stem cells lurking in tumors can resist treatment
Scientists are eager to make use of stem cells’ extraordinary power to transform into nearly any kind of cell, but that ability also is cause for concern in cancer treatment. Malignant tumors contain stem cells, prompting worries among medical experts that the cells’ transformative powers help cancers escape treatment.
Combining stem-cell therapy with anti-scarring agent may heal injured kidneys
Researchers have made a discovery that could see patients with kidney disease no longer having to resort to dialysis or kidney transplants. Chronic kidney disease can be caused by a number of factors, and results in permanent, irreversible scarring of the kidney leading to end-stage renal disease. Once a patient has reached this point their only option is dialysis or transplantation.
EMERGING MEDICAL TECHNOLOGIES
FDA approves new CPR devices that may increase cardiac arrest survival
By Lynn Hetzler
Only 7 percent of the 300,000 people who suffer cardiac arrests outside of hospitals each year survive, according to the Centers for Disease Control and Prevention, despite the fact that two-thirds of these patients receive treatment from emergency medical service providers. But help is on the way. The U.S. Food and Drug Administration recently approved new CPR devices that might improve patient's chances of surviving cardiac arrest.
ACCOUNTABLE CARE ORGANIZATIONS
White House launches 'Next Generation ACO' with high-touch value-based care
The Centers for Medicare & Medicaid Services said it plans to launch the next generation of value-based medical care, expanding what doctors and hospitals can do via the accountable care organization model of care.
Early results from Medicaid ACO programs show promise
For the past few years, skeptics have questioned whether accountable care organizations actually meet their goal of creating long-term savings. Early results from Medicaid ACO programs in Colorado, Oregon and Minnesota may prove them wrong, according to a blog post from the Commonwealth Fund.
FDA: NEW TREATMENTS AND TECHNOLOGY
FDA panel backs Kythera double-chin treatment
The Wall Street Journal
Kythera Biopharmaceuticals Inc. said that a Food and Drug Administration advisory panel voted unanimously to recommend approval of the company’s injectable drug to treat adult submental fat, or what is commonly known as a double chin.
FDA approves United Therapeutics' drug for treating cancer in children
The Food and Drug Administration said it approved United Therapeutics Corp's drug to treat neuroblastoma, a rare cancer that typically occurs in children below 5 years.
Unituxin is the first drug approved to treat high-risk neuroblastoma patients who have a greater chance of tumors recurring or progressing after chemotherapy.
New report provides real answers in era of health advice overload
By Natalie Rodriguez
The recent release of the Scientific Report of the 2015 Dietary Guidelines Advisory Committee has American health nuts jumping for joy. This 571-page report of medical and scientific research promotes a "culture of health," in which a healthy lifestyle is "easy, accessible, affordable and normative." This may finally be the answer to our collective cry for sound health advice. The truth is Americans in the digital age are generally confused about their health. New studies emerge every minute, it seems, on the greatest options for the healthiest lifestyle.
Obamacare gets health insurance to 16M new people
More than 16 million people who did not have health insurance before have gained it through the 2010 Affordable Care Act, also known as Obamacare, the federal government said.
More than 14 million adults have health insurance either from the new exchanges or through expanded access to Medicaid, the Health and Human Services Department said.
Funding, focus lacking for healthcare that gets results
As the Affordable Care Act pushes doctors and hospitals to join forces to slash healthcare costs, those with the least-expensive solutions say they're still largely being ignored.
Community health groups and companies that specialize in healthy eating and fitness are arguing for more recognition of non-medical ways to prevent and treat chronic conditions such as diabetes, hypertension and heart disease.
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063